Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion

Author:

Ren Wenlin1,Ju Xiaohui1,Gong Mingli1,Lan Jun2,Yu Yanying1,Long Quanxin3ORCID,Kenney Devin J.45,O’Connell Aoife K.45,Zhang Yu1,Zhong Jin6ORCID,Zhong Guocai78ORCID,Douam Florian45,Wang Xinquan2,Huang Ailong3,Zhang Rong9,Ding Qiang1ORCID

Affiliation:

1. Center for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing, China

2. School of Life Sciences, Tsinghua University, Beijing, China

3. Key Laboratory of Molecular Biology on Infectious Diseases, Ministry of Education, Chongqing Medical University, Chongqing, China

4. Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA

5. National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA

6. Unit of Viral Hepatitis, CAS Key Laboratory of Molecular Virology and Immunology, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China

7. Shenzhen Bay Laboratory, Shenzhen, China

8. School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China

9. Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Biosafety Level 3 Laboratory, Fudan University, Shanghai, China

Abstract

SARS-CoV-2, the causative agent of pandemic COVID-19, is rapidly evolving to be more transmissible and to exhibit evasive immune properties, compromising neutralization by antibodies from vaccinated individuals or convalescent-phase sera. Recently, SARS-CoV-2 variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 with mutations within the spike proteins were identified in India.

Funder

Beijing Municipal Natural Science Foundation

Start-up Foundation of Tsinghua University

Tsinghua University Spring Breeze Fund

Advanced Customer Cultivation Project of Wuhan National Biosafety Laboratory, CAS

National Natural Science Foundation of China

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3